Citation Impact
Citing Papers
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure
2007
Carotid body denervation improves autonomic and cardiac function and attenuates disordered breathing in congestive heart failure
2013
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
2008 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Baseline Characteristics and Treatment of Patients in Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF)
2014
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure
2004
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
2008 Standout
Nicotinic acetylcholine receptors: from structure to brain function
2003
Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program
2008
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
2010 Standout
Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study
2014
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
2004 Standout
Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation
2007
The Failing Heart — An Engine Out of Fuel
2007 Standout
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
2019
Exercise Standards for Testing and Training
2013 Standout
Flexible polymer transistors with high pressure sensitivity for application in electronic skin and health monitoring
2013 Standout
Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association
2012
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
The perindopril in elderly people with chronic heart failure (PEP-CHF) study
2006 Standout
Endothelial Dysfunction, Arterial Stiffness, and Heart Failure
2012
Acute kidney injury
2019 Standout
Atrial Functional Mitral Regurgitation
2019
Prevention of Heart Failure
2008
Microvascular brain damage with aging and hypertension
2011
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia
2010
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
2018 Standout
Thyroid Hormone Analogues for the Treatment of Metabolic Disorders: New Potential for Unmet Clinical Needs?
2012
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Home-based versus centre-based cardiac rehabilitation
2010
Tiratricol-Induced Periodic Paralysis: a review of nutraceuticals affecting thyroid function
2011
Heart failure
2005
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
The Pathobiology of Vascular Dementia
2013 Standout
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Adverse Effects of Combination Angiotensin II Receptor Blockers Plus Angiotensin-Converting Enzyme Inhibitors for Left Ventricular Dysfunction
2007
Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry
2008
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association
2012
Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes
2006 Standout
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
New Roles for β-Arrestins in Cell Signaling: Not Just for Seven-Transmembrane Receptors
2006 StandoutNobel
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Mechanisms of thyroid hormone action
2012
Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I‐PRESERVE trial
2008
American Thyroid Association Guide to Investigating Thyroid Hormone Economy and Action in Rodent and Cell Models
2013
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Thyroid Hormone Analogues: Where Do We Stand in 2013?
2013
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Arterial Stiffness and Cardiovascular Events
2010 Standout
Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: effect of endurance exercise training
2009
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
2006 Standout
Determinants of Elevated Pulse Pressure in Middle-Aged and Older Subjects With Uncomplicated Systolic Hypertension
2003
Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases
2003 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Efficacy and Safety of Longer-Term Administration of Evolocumab (AMG 145) in Patients With Hypercholesterolemia
2013
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Detrimental effects of thyroid hormone analog DITPA in the mouse heart: increased mortality with in vivo acute myocardial ischemia-reperfusion
2010
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Thyroid Hormone Regulation of Metabolism
2014 Standout
Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure
2005
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Epigenetic regulation of redox state mediates persistent cardiorespiratory abnormalities after long‐term intermittent hypoxia
2016 StandoutNobel
Diiodothyropropionic Acid (DITPA) in the Treatment of MCT8 Deficiency
2012
The BEAUTIFUL Study: Randomized Trial of Ivabradine in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction – Baseline Characteristics of the Study Population
2007
Comorbidity and Ventricular and Vascular Structure and Function in Heart Failure With Preserved Ejection Fraction
2012
Treatment With Thyroid Hormone
2014
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Omapatrilat Reduces Pulse Pressure and Proximal Aortic Stiffness in Patients With Systolic Hypertension
2002
Time-Varying Myocardial Stress and Systolic Pressure-Stress Relationship
2009
Pulse Wave Analysis of the Aortic Pressure Waveform in Severe Left Ventricular Systolic Dysfunction
2009
Works of Mark E. Dunlap being referenced
In-Hospital Resource Use and Medical Costs in the Last Year of Life by Mode of Death (from the HF-ACTION Randomized Controlled Trial)
2012
Augmentation Index and Central Aortic Stiffness in Middle-Aged to Elderly Individuals
2007
Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial
2006
Incidence and Predictors of Hyperkalemia in Patients With Heart Failure
2007
Characterization of health‐related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM
2006
Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
2005
Long-Term Trandolapril Treatment Is Associated With Reduced Aortic Stiffness
2007
835-5 Candesartan improves functional class across a broad spectrum of patients with chronic heart failure: Results of the candesartan in heart failure-assessment of reduction in mortality and morbidity programme (CHARM)
2004
Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction
2004
DITPA (3,5-Diiodothyropropionic Acid), a Thyroid Hormone Analog to Treat Heart Failure
2009
Aortic Diameter, Wall Stiffness, and Wave Reflection in Systolic Hypertension
2007
Functional Nicotinic Acetylcholine Receptors That Mediate Ganglionic Transmission in Cardiac Parasympathetic Neurons
2000
Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure
1999
Effects of the Thyromimetic Agent Diiodothyropropionic Acid on Body Weight, Body Mass Index, and Serum Lipoproteins: A Pilot Prospective, Randomized, Controlled Study
2010
Pulsatile Hemodynamics in Congestive Heart Failure
2001
Sympathetically Mediated Changes in Capacitance
2011